Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With Diabetes
Public ClinicalTrials.gov record NCT07619729. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Study to Evaluate the Efficacy of an Oral Health Behavioral Intervention on Medical and Dental Claims in People With Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical study is to evaluate the effect of a behavioral intervention on the number of preventive and treatment dental claims in a population of people with Type 2 Diabetes.
Study identification
- NCT ID
- NCT07619729
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 10,000 participants
Conditions and interventions
Conditions
Interventions
- Diabetes Oral Health Program Behavioral
- Stannous Fluoride Dentifrice Drug
- Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash Drug
Behavioral · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 25, 2026
- Primary completion
- Jan 1, 2028
- Completion
- Jan 1, 2028
- Last update posted
- Jun 2, 2026
2026 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Decentralized Site - Virtual/Remote (NY, USA) | Long Island City | New York | 11101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Diabetes Type 2 trials
Other public records listing Diabetes Type 2. Sorted by last update posted; newest first. Not a recommendation.
- NCT05071898: Pharmacogenetics of Response to GLP1R Agonists Recruiting
- NCT05912647: Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes Recruiting
- NCT07689877: Glucose, Understanding, Integrated Digital Health, and Engagement (GUIDE) Study Not yet recruiting
- NCT07376655: Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life Recruiting
- NCT07400653: A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) Recruiting
- NCT07135531: Continuous Glucose Monitoring (CGM) in an Underserved Population Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07619729, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07619729 live on ClinicalTrials.gov.